Coya Therapeutics, Inc. (COYA) — Stock Valuation & Research

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND)…

COYA key statistics

Price$3.15
Market cap$73.77M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range3.03-6.62
Beta0.58

Explore COYA's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.